Interleukin-18 mediates interleukin-1-induced cardiac dysfunction. - Test2 - elhamkhani - TriplyDB

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

http://www.wikidata.org/entity/Q37656103

about

IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.Role of Interleukin-1 in Radiation-Induced Cardiomyopathy.The Importance of NLRP3 Inflammasome in Heart Failure Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell Disease Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism.Targeting interleukin-1 in heart failure and inflammatory heart disease.Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts Targeting danger-associated molecular patterns after myocardial infarction.Relaxin' the Heart: A Novel Therapeutic Modality.Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction.Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse.Interleukin-18 increases TLR4 and mannose receptor expression and modulates cytokine production in human monocytes.Diastolic dysfunction in chronic hypoxia: IL-18 provides the elusive link.Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.Overview of the IL-1 family in innate inflammation and acquired immunity.Interleukin-18: Biological properties and role in disease pathogenesis.The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model.ASC Methylation and Interleukin-1β Are Associated with Aerobic Capacity in Heart Failure.Insights into innate immune signalling in controlling cardiac remodelling.Association of EGF Receptor and NLRs signaling with Cardiac Inflammation and Fibrosis in Mice Exposed to Fine Particulate Matter.Anti-inflammatory treatment of acute coronary syndromes: the need for precision medicine.Myocarditis: An Interleukin-1-Mediated Disease?Cardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac Repair Anakinra Therapy for Non-cancer Inflammatory Diseases

P2860

Q28072571-E67DB458-E0FC-4E88-B78A-C354377E7BAA Q33801215-EA282AB0-B525-4063-B6B2-87FB14127C04 Q34150569-365F8C99-B23A-4F0D-B17B-6DA051DC16AB Q34497232-8D2C8B95-803E-452A-AC1B-561037DAECE5 Q34501403-3EF1248E-BCE6-4958-A103-07D88F1C1CAD Q35171781-121A74D8-7780-454D-8D38-239DAA54BAA2 Q35847003-83F73029-81F0-4648-82AD-457209ACD21F Q35855691-6F545E6E-D4BB-4094-A5A9-9B0B37ED61E2 Q35891957-695A071F-F5B8-46F6-8E56-817763735A34 Q36135607-E4838B15-6E6A-47A5-A947-987017B3087B Q36698712-54FD2D0B-8300-4D2C-BCE7-3A698A237F87 Q37541407-0EB36BE7-DF3F-43C8-8389-06929EAE1082 Q38260179-9269D8C0-616B-4415-A09C-23C58DFE100D Q38408014-654C02E6-4DA6-4DE4-9D5A-332F7AE8039C Q38566665-BCF6FB0C-66E4-4F89-B3EA-B43DAD04C268 Q38595544-F3CAB8D0-D8ED-4D4F-B59E-2190E902F9BF Q38940630-7DA0D310-8033-4B07-8430-AB95B40A0CE2 Q39612410-670E186D-9C02-4C78-AAE1-DCDBCC025E7F Q42258755-898574EF-2CA9-4A19-B87D-A685493FF038 Q43214205-46277A21-92C3-44F6-9C97-0E660CE26A6F Q45004217-D2103FE5-10CE-41B3-888D-495141638C6D Q45050521-2494C678-DC16-4BBC-A56D-D85BAA75A2F3 Q47285878-150E6CB8-54B5-4B43-B8BD-191CEE00BCE9 Q47285927-B31F0FE0-1756-48A4-A83E-5D2ECE608328 Q47288476-7CECB62F-14D8-46BD-8DB3-A7F6B0E976DB Q47644899-757BCF09-D852-40C6-853C-A89EC201022E Q48124340-416FFE50-1F09-439C-9848-616EB9F40DD2 Q51202602-F12FD5FF-1C76-461E-BC33-A9CCBBDDEBDA Q52448624-0FAE1209-B5C6-4B4F-9169-98A8C0B9898C Q53104133-A8C541F7-95F7-4174-96F9-CFFD4E8644D9 Q54488428-ED1F5A65-FBC5-4C83-8FCF-B9B67250D15A Q55397626-41C9D015-2973-4ECD-B9B3-2D1A945C53B0 Q58586099-76ABCF08-DE9C-4C14-85C9-3C6BBD4C13DF Q59136398-397EC32C-882F-4EAF-8BD4-B3D698D6D305

P2860

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

http://www.wikidata.org/entity/Q37656103

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

@en

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

@nl

type

label

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

@en

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

@nl

prefLabel

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

@en

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

@nl

P1433

Q37656103-827EA1D3-4955-43CC-8A4C-F34DDD72F455

P1476

Q37656103-6BCBDF74-0C54-406F-8921-E1CD130B640B

P2093

Q37656103-425159EE-F0C7-4ED0-A161-F5A309134612

Q37656103-45FFA22B-C0C8-4A58-B195-8E47945489E4

Q37656103-7682CF96-363D-4499-B79B-B3E7C91C75B0

Q37656103-8316DBE7-423F-423B-8811-F6C2ADC9EBD3

Q37656103-9BF5B7C6-D4C8-4C54-8F98-6755147DBEF5

Q37656103-BCFBB8BC-3BC9-4FB8-996D-09AE49E25455

Q37656103-EFD05BEA-AB94-4F17-9E6A-5779340B7A2E

Q37656103-FB70921D-3E22-468A-A632-E40D4C9DE873

P2860

Q37656103-028FCC62-39EB-4892-943D-FD7632691448

Q37656103-119F13AB-2848-4BA7-A32F-31618AC2F38E

Q37656103-1816E4C2-7F28-4FC3-A1C8-520953B32D5D

Q37656103-1A5C2840-A39F-4354-BE77-FE9D37B036C5

Q37656103-265F448D-8B5E-4356-B1B1-11AF6CBE7204

Q37656103-392D3069-B9BF-4A08-A3D1-A612BBD7E4DC

Q37656103-482136E2-8CBC-4C97-943B-12C3FEA21381

Q37656103-48DC478F-11C1-4F66-B6A7-C00CCBC4566B

Q37656103-48F19ACE-7564-40C1-9A43-8F63558F1E1C

Q37656103-4BADCA6C-60B3-434E-AF8E-3B22D77A4BC0

P304

Q37656103-8A8F9F44-3E88-4883-8DFE-1B241C36CAC8

P31

Q37656103-E43FB0F1-3757-4E6A-B0A6-D0CFD3F7A54C

P356

Q37656103-ECB0B197-3FA3-4AB8-8B51-CF22FA1E3486

P433

Q37656103-AC9BAC8F-0EC1-456C-8AF9-73BA1E564963

P478

Q37656103-7127FD78-F4C1-4625-A475-6462E54FE5E6

P50

Q37656103-6AC3AD4B-EF21-48B6-9A89-E6580D2CCECA

P577

Q37656103-1CC80258-9423-459C-BBA1-8F8075A276E0

P5875

Q37656103-16DE8F47-D622-4EBC-96CA-1BB35C68ACE9

P698

Q37656103-5382FD94-7664-408F-BA1B-65A2138D2A38

P921

Q37656103-fd26c6e1-e1fa-4979-9108-d22540e106e9

P932

Q37656103-CB3058A6-A69B-44AE-9B20-EE73D3028C1D

P356

AJPHEART.00795.2013

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

@en

P2093

Antonio Abbate

http://www.w3.org/2001/XMLSchema#string

Benjamin W Van Tassell

http://www.w3.org/2001/XMLSchema#string

Carlo Marchetti

http://www.w3.org/2001/XMLSchema#string

Eleonora Mezzaroma

http://www.w3.org/2001/XMLSchema#string

Ignacio M Seropian

http://www.w3.org/2001/XMLSchema#string

Laura O'Brien

http://www.w3.org/2001/XMLSchema#string

Norbert F Voelkel

http://www.w3.org/2001/XMLSchema#string

Stefano Toldo

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Targeting interleukin-1 in heart disease

Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure

IL-37: a new anti-inflammatory cytokine of the IL-1 family.

Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure.

Right ventricular dysfunction following acute myocardial infarction in the absence of pulmonary hypertension in the mouse.

Circulating cytokines as mediators of fever.

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

P304

H1025-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00795.2013

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P50

Charles A. Dinarello

P577

2014-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260211272

http://www.w3.org/2001/XMLSchema#string

P698

24531812

http://www.w3.org/2001/XMLSchema#string

P921

P932

3962640

http://www.w3.org/2001/XMLSchema#string